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ABSTRACT 
 
Observational studies have suggested anthropometric traits, particularly increased height are 
associated with an elevated risk of testicular cancer (testicular germ cell tumour, TGCT). However, 
there is an inconsistency between study findings, suggesting the possibility of the influence of 
confounding factors. To examine the association between anthropometric traits and TGCT using 
an unbiased approach, we performed a Mendelian randomisation (MR) study. We used genotype 
data from genome wide association studies (GWAS) of TGCT totalling 5,518 cases and 19,055 
controls. Externally weighted polygenic risk scores were created and used to evaluate associations 
with TGCT risk per one standard deviation (s.d) increase in genetically-defined adult height, adult 
BMI, adult waist hip ratio adjusted for BMI (WHRadjBMI), adult hip circumference adjusted for 
BMI (HIPadjBMI), adult waist circumference adjusted for BMI (WCadjBMI), birth weight (BW) and 
childhood obesity. MR analysis did not demonstrate an association between any anthropometric 
trait and TGCT risk. In particular, despite good power, there was no global evidence for association 
between height and TGCT.  However, three SNPs for adult height individually showed association 
with TGCT (rs4624820: OR=1.47, 95% CI: 1.41-1.55, P=2.7×10-57; rs12228415: OR=1.17, 95% CI: 
1.11-1.22, P=3.1×10-10; rs7568069: OR=1.13, 95% CI: 1.07-1.18, P=1.1×10-6). This MR analysis, 
based on the largest TGCT GWAS dataset to date, does not support a causal etiological association 
between anthropometric traits and TGCT aetiology. Our findings are more compatible with 
confounding by shared environmental factors, possibly related to prenatal growth with exposure 
to these risk factors occurring in utero.  
 
INTRODUCTION 
 
Testicular cancer (testicular germ cell tumour, TGCT) has doubled in incidence over the last 30 
years in Western Countries and has an unusual incidence rate in comparison to many other 
neoplasms with rates peaking at ~30 years and declining rapidly thereafter (Bray et al. 2006; Le 
Cornet et al. 2014; Ruf et al. 2014). Tumours with this kind of age-incidence profile are likely to 
have onset early in life, and previous studies have therefore focussed on perinatal and adolescent 
stages of development as well as adult anthropometric traits (Akre et al. 2000; Bjørge et al. 2006; 
Dieckmann & Pichlmeier, 2002; Dieckmann et al. 2009; Garner et al. 2003; McGlynn et al. 2007; 
Rasmussen et al. 2003; Richiardi et al. 2003). Although there is disagreement as to the effect of 
adult body mass index (BMI) on TGCT risk many, but not all, studies have reported increased 
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height as a risk factor for the disease (Akre et al. 2000; Bjørge et al. 2006; Dieckmann & 
Pichlmeier, 2002; McGlynn et al. 2007; Rasmussen et al. 2003; Richiardi et al. 2003). However, 
none of these studies have established causal pathways linking traits such as height with TGCT, 
with some studies suggesting that confounding environmental factors such as childhood nutrition 
could play a greater role. 
An alternative approach to a traditional epidemiology observational study is the Mendelian 
randomisation (MR) approach. The strategy of MR uses as instrumental variables (IV) genetic 
markers known to be associated with a factor in the assessment of its effect on another trait 
(Palmer et al. 2012). This methodology permits the nature of the relation between the trait and 
the factor to be assessed and, importantly, establishes whether an association is causal. A further 
attribute of MR is the avoidance of the influence of factors whose effect may be time sensitive, for 
example temporal trends in calorific intake. Therefore, a genetically defined IV has the potential to 
more accurately assess lifetime exposure when compared to measurements of potential risk 
factors recorded in an observational study.   
Recent genome-wide association studies (GWAS) have identified single nucleotide polymorphisms 
(SNPs) at multiple loci that are robustly associated with height and other anthropometric traits 
(Locke et al. 2015; Wood et al. 2014). Given the unexplained recent rapid increase in TGCT 
incidence, the paucity of established risk factors for TGCT and the mixed observational 
epidemiology on the association of anthropometric traits with TCGT risk, we performed a MR 
study by analysing genotype data from three GWAS conducted on TGCT (Kristiansen et al. 2015; 
Turnbull et al. 2010). The traits we considered were adult height, adult BMI, adult waist-hip ratio 
adjusted for BMI (WHRadjBMI), adult waist circumference adjusted for BMI (WCadjBMI), adult hip 
circumference adjusted for BMI (HIPadjBMI), childhood obesity and birth weight (BW). 
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MATERIALS AND METHODS 
 
Testicular cancer GWAS data sources  
Our MR analysis was based on data from three previously reported GWAS of TGCT totalling 5,518 
cases and 19,055 controls. Briefly, these GWAS were based on individuals with European ancestry 
and comprised: UK GWAS1 (985 cases, 4,946 controls), UK Oncoarray (3,206 cases, 7,422 
controls), and Scandinavian GWAS1 (1,327 cases, 6,687 controls). Details of the genotyping, 
quality control and imputation of untyped SNPs have been previously published (Kristiansen et al. 
2015; Turnbull et al. 2010). Briefly, we excluded SNPs with a minor allele frequency of <1%, a call 
rate <95%, those SNPs violating Hardy-Weinberg equilibrium, and individuals with non-European 
ancestry as assessed using data from HapMap v2 (International HapMap et al. 2007). IMPUTEv2 
software (Howie et al. 2012) was used to recover untyped SNP genotypes using a merged 
reference panel consisting of UK10K and 1000 Genomes Project data. Poorly imputed SNPs, 
defined by an INFO score of <0.9, were excluded. Summary statistics from these GWAS were used 
to calculate the ratio estimates for the anthropometric-related SNPs.   
 
Instrumental variables  
For each anthropometric trait we used data from recent GWAS of individuals of European-
descent. Specifically for height, we used data from the Genetic Investigation of Anthropometric 
Traits (GIANT) consortium, which was based on an analysis of up to 253,288 individuals (Wood et 
al. 2014). For adult BMI, data was obtained from a consortium meta-analysis comprising 339,224 
individuals from 125 studies (Locke et al. 2015). Data for WHRadjBMI, WCadjBMI and HIPadjBMI 
were obtained from related consortium meta-analyses comprising up to 224,459 individuals 
(Shungin et al. 2015). Data reported by the Early Growth Genetics (EGG) consortium of a meta-
analysis of 5,530 cases and 8,318 controls was used for childhood obesity (Bradfield et al. 2012). 
Birth weight data was obtained from a meta-analysis of up to 69,308 individuals from 43 studies 
(Horikoshi et al. 2013).  
To calculate the genetic scores we considered only SNPs that were genome-wide significant (P < 
5×10-8) for each anthropometric trait and were present in all three GWAS TCGT datasets. To avoid 
co-linearity between SNPs we imposed a threshold R2 value of ≥0.8 for linkage disequilibrium (LD) 
including only the SNPs with the strongest effect on the trait in the genetic risk score. After 
imposing these metrics we analysed 379 SNPs for adult height, 69 SNPs for adult BMI, 44 SNPs for 
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WHRadjBMI, 25 SNPs for WCadjBMI and 10 SNPs for HIPadjBMI, seven SNPs for birth weight and 
seven SNPs for childhood obesity.  
We also examined male-specific risk-associated SNPs. However, because of a paucity of data, we 
relaxed the significance threshold and considered all SNPs at P < 1.0×10-7. Imposing this criteria 
provided seven male-specific SNPs for WHRadjBMI, four for HIPadjBMI and nine for WCadjBMI 
(Randall et al. 2013). Fifteen SNPs displaying significant male dimorphism for adult height were 
also considered (Randall et al. 2013). For all SNPs used, we recovered the chromosome position, 
risk alleles, association estimates and standard errors. None of the GWAS that comprised our 
dataset had reported non-additive effects of the SNPs, hence per allele effects were considered 
additive. For each SNP, we extracted the respective effect estimates and P-values from the TGCT 
GWAS.  
 
Statistical Analysis 
A central assumption of MR analysis is that there is no pleiotropism between the genetic 
instruments influencing TGCT and the trait being tested. Prior to performing MR, we used linkage 
disequilibrium regression (LDR) to test for global pleiotropy and used MR-Egger and inverse-
variance weighted (IVW) regression to examine standard IV assumptions (Bowden et al. 2015). 
LDR was performed for TGCT against each trait to estimate genetic covariance with TGCT (Bulik-
Sullivan et al. 2015).  
We performed MR analysis to assess the association between each anthropometric trait and TGCT 
using summary statistics (Burgess et al. 2015). Using this method, the combined ratio estimate (?̂?) 
of all SNPs associated with the particular risk factor on TGCT was calculated under a fixed effects 
model:  
?̂? =  
∑ 𝑋𝑘𝑌𝑘𝜎𝑌𝑘
−2
𝑘
∑ 𝑋𝑘
2𝜎𝑌𝑘
−2
𝑘
 
where 𝑋𝑘 represents the anthropometric trait effect size for SNP k, 𝑌𝑘 represents the TGCT risk 
effect size for SNP k and 𝜎𝑌𝑘 denotes the standard error in the value of 𝑌𝑘. The standard error of 
the TGCT risk effect size, denoted by 𝑠𝑒(?̂?), is given by:  
𝑠𝑒(?̂?) =  √
1
∑ 𝑋𝑘𝜎𝑌𝑘
−2
𝑘
 
With the statistics generated by following these calculations on the three different cohorts in the 
TGCT data, we performed a meta-analysis under a fixed-effects model to derive the final odds 
ratios and confidence intervals. 
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For each statistical test we considered a global nominal significance level of P≤0.05 as satisfactory 
to derive conclusions. A Bonferroni correction was applied to significance levels to compensate for 
multiple testing. All analyses were undertaken using R software (Version 2.14.1). 
To gain biological insight into individual SNPs associated with both TGCT and anthropometric 
traits, we investigated the effects of significantly associated individual SNPs on gene expression 
using the GTEx resource, examining association with expression of all genes within 1MB of the 
associated SNP (Lonsdale et al. 2013).  
Finally, we estimated the power of our MR analysis to demonstrate an association between TGCT 
and anthropometric traits tested over a range of effect sizes (Brion et al. 2013).  
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RESULTS 
 
Using LDR we found no evidence for global pleiotropism between TGCT and any of the 
anthropometric traits after correction for multiple testing (Supplementary Table 1). Of the seven 
tested anthropometric traits and four male-specific components of traits, the strongest correlation 
was found between TGCT and childhood obesity (Genetic Correlation (GC) = 0.14, 95% confidence 
interval (CI) -0.26, -0.012, P = 0.032). MR-Egger and IVW regression tests provided no evidence of 
infringement of the standard IV assumptions (Supplementary Fig. 1 - 11, Supplementary Tables 2 
and 3). All genetic variants used were therefore considered valid IVs and the following MR analysis 
valid.   
MR analysis found no evidence for a genetic relationship between any of the seven 
anthropometric traits and TGCT risk (Table 1). To explore the effect of male dimorphism we 
additionally performed MR using IVs generated from male-specific SNPs for four of the 
anthropometric traits. This restricted analysis found no relationship between any IV and TGCT risk 
(Table 1). 
Although in the LDR analysis we found no evidence for a global pleiotropism between height and 
TGCT, three of the IV SNPs for height showed a strong association with TGCT risk, even after 
applying a Bonferroni correction for testing 379 SNPs (rs4624820 (5q31.3): OR 1.47, 95% CI 1.41-
1.55, P=2.7×10-57; rs12228415 (12p13.1): OR 1.17, 95% CI 1.11-1.22, P=3.1×10-10; and rs7568069 
(2p13.3): OR 1.13, 95% CI 1.07-1.18, P=1.1×10-6). Only rs7568069 showed a significant eQTL effect 
in testicular tissue (for DYSF, P = 5.8×10-6). No other trait tested had any SNP associated with TGCT 
risk.  
Analyses of the power afforded by these MR analyses for each anthropometric trait analysed are 
shown in Supplementary Figs. 12-15. Since the IV SNPs for adult height explain ~20% of variance of 
the trait (Wood et al. 2014), our study has 90% power to detect an OR≥1.1. In contrast, the SNPs 
used as IVs for adult BMI only account for 3% of the variation (Locke et al. 2015), and hence we 
had <30% power to detect an OR≥1.1. Similarly, we had <20% power to demonstrate associations 
for WHRadjBMI and birth weight for effect sizes of OR≥1.1.  
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DISCUSSION 
 
Following up upon associations reported in observational epidemiological studies between 
anthropometric traits and TGCT, our MR analysis using a TGCT GWAS dataset did not find an 
association between any anthropometric trait tested and risk. Although based on large datasets, 
aside from adult height, the SNP sets used as IVs only account for a modest proportion of the 
genetic variance underlying the anthropometric traits analysed. Hence we cannot exclude the 
possibility that null findings were simply a consequence of limited study power.  
The primary motivation for this study was to further explore the epidemiological evidence for a 
positive relationship between adult height and TGCT, which has been reproduced across a number 
of studies (Akre et al. 2000; Bjørge et al. 2006; Dieckmann & Pichlmeier, 2002; McGlynn et al. 
2007; Rasmussen et al. 2003; Richiardi et al. 2003). Despite 90% power to detect an OR>1.1, in our 
MR analysis we did not find global genetic evidence supporting a role of height in TGCT aetiology. 
These results suggest that the observed association between height and TGCT, if true, may be due 
to the influence of confounding due to shared environmental factors (Dieckmann et al. 2008). 
Although we found no evidence of global pleiotropism between height and TGCT through LDR, our 
results, however, do not discount pleiotropic influences of individual SNPs on both adult height 
and TGCT development. Interestingly, three SNPs associated with increased height also showed a 
strong association with TGCT risk. The strongest of these SNPs, rs4624820 (5q31.3), is within the 
previously well-established TGCT-associated locus containing SPRY4 (Kanetsky et al. 2009; Rapley 
et al. 2009; Turnbull et al. 2010). Another of these SNPs, rs7568069 (2p13.3), showed a significant 
eQTL effect in testicular tissue of DYSF (Dystrophy-Associated Fer-1-Like 1), which has been 
implicated in both muscular growth and developmental processes including sperm activation 
during fertilization and early embryogenesis (Smith & Wakimoto, 2007). While these results are 
consistent with overlapping pleiotropic pathways for these variants, these three SNPs are among 
379 instrumental variables for height and contribute very modestly individually or in combination 
to each trait (Cole, 2000; Le Cornet et al. 2014).  
A number of studies have suggested that BMI plays a role in TGCT risk (Akre et al. 2000; 
Dieckmann et al. 2009; Garner et al. 2003), although others have found no significant positive or 
negative association (Bjørge et al. 2006; Dieckmann & Pichlmeier, 2002; Rasmussen et al. 2003). 
Physical activity was found in one study to have a preventative effect on TGCT risk (Gallagher et al. 
1995). There is some evidence for a negative association of BMI from a dataset of 500,000 
Norwegian men (Akre et al. 2000); examining our Scandinavian cohort alone, waist circumference 
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adjusted for BMI displayed a nominally significant (P = 0.04) preventative association with TGCT 
risk but there were no other associations of note. Globally we did not find genetic evidence for a 
role in TGCT of BMI, waist circumference, or any other related traits. However, we acknowledge 
our power to detect an association of BMI and related anthropometric traits with TGCT using MR 
was limited. Accordingly, our null results therefore do not further clarify whether the reported 
association between BMI and related anthropometric traits with TGCT are true or not, and if true, 
whether causal or due to the confounding influence of common environmental factors. Similarly, 
MR analyses for association of both birth weight and childhood obesity on TGCT risk were subject 
to low power. To be more informative, further MR analysis of these traits would require 
significantly larger SNP sets capturing a higher proportion of phenotypic variation.  
In summary, in our MR analysis we found no evidence for influence of adult height, BMI or other 
anthropometric traits in TGCT aetiology. Our MR analysis of height with TGCT was well-powered, 
and our null result suggests that the previously reported positive association between height and 
TGCT, if a true association, is unlikely to be driven by a common aetiology but instead is more 
likely to reflect confounding. Several potential mechanisms underlying the association between 
height and TGCT have previously been postulated, such as individual variation in the insulin-like 
growth factor I system (Zavos et al. 2004), age at puberty (Akre et al. 2000), and childhood 
nutrition (Dieckmann et al. 2008). Molecular and epidemiological data support a model whereby 
initial neoplastic transformation into the TGCT precursor lesion arises during the foetal period with 
the pre-invasive TGCT lesion lying dormant through childhood into adolescence and malignant 
growth finally occurring in early adulthood (Jacobsen & Henriques, 1992; Kristensen et al. 2008; 
Oosterhuis & Looijenga, 2005; Rajpert-De Meyts, 2006; Skakkebaek et al. 1987). This model of 
prenatal determination of TGCT would therefore be consistent with proposed exposure to an 
environmental factor common to adult height and TGCT risk occurring in utero. It is therefore 
plausible that foetal nutrition or another maternal or in utero exposure is positively associated 
with each of adult height and TGCT, thus potentially driving the observed association between 
these traits. Although much epidemiological study has examined association of maternal and in 
utero exposures with TGCT, to date no compelling evidence that implicates any specific pre-natal 
risk factors in the aetiology of TGCT has emerged from these studies (McGlynn & Cook, 2009). 
In conclusion, although the genomic basis of TGCTs is becoming increasingly well understood 
(Litchfield et al. 2016), the environmental factors underlying the rapid increase in incidence of 
TGCT over the last four decades remain unclear. From the MR analyses we have presented, it is 
likely that if any of the associations of TGCT with anthropometric variables are true, they are a 
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product of confounding influence from early-life environmental exposures which are yet to be 
elucidated.  
 
Table 1 Meta-analysis results of Mendelian Randomisation (MR) for anthropometric phenotypes 
against TGCT risk. MR was performed for each phenotype against three cohorts. 
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Phenotype OR (95% CI)  P-value I2 Phet 
Adult Height 1.066 (0.968 – 1.173) 0.197 25.70 0.260 
Adult Height (Male only) 0.922 (0.600 – 1.416) 0.710 62.89 0.068 
Adult BMI 0.848 (0.658 – 1.093) 0.203 9.79 0.330 
WHRadjBMI 0.956 (0.712 – 1.284) 0.767 0 0.649 
WHRadjBMI (Male only) 1.388 (0.755 – 2.551) 0.292 0 0.579 
WCadjBMI 1.163 (0.787 – 1.719) 0.449 58.83 0.088 
WCadjBMI (Male only) 1.245 (0.720 – 2.150) 0.433 27.46 0.252 
HIPadjBMI 1.664 (0.936 – 2.957) 0.083 53.83 0.115 
HIPadjBMI (Male only) 0.996 (0.498 – 1.994) 0.991 0 0.507 
Childhood Obesity 0.863 (0.673 – 1.107) 0.246 0 0.517 
Birth Weight 1.149 (0.783 – 1.687) 0.478 0 0.599 
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